AstraZeneca Set To Gain From New Asthma Drug – Seeking Alpha

AstraZeneca Set To Gain From New Asthma Drug
Seeking Alpha
AstraZeneca and Rigel Pharmaceuticals (RIGL) have agreed to work together on a chronic asthma drug. The drug in question is R256, which is Rigel's "inhaled

View full post on asthma – Google News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.